Do molecularly targeted agents in oncology have reduced attrition rates?
Walker
Ian
I
Newell
Herbie
H
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D015195:Drug Design; D006801:Humans; D009369:Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents